These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6235611

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transfusion induces blood donor-specific suppressor cells.
    Quigley RL, Wood KJ, Morris PJ.
    J Immunol; 1989 Jan 15; 142(2):463-70. PubMed ID: 2521347
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prolonged survival of rat hepatic allografts pretreated with a single donor-specific blood transfusion: the distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient.
    Yamaguchi Y, Goto M, Makino Y, Kikuchi N, Hamaguchi H, Hisama N, Miyanari N, Mori K, Ogawa M.
    J Surg Res; 1996 Feb 15; 61(1):23-9. PubMed ID: 8769937
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Infectious tolerance mediated by CD8+ T-suppresor cells after UV-B-irradiated donor-specific transfusion and rat heart transplantation.
    Witkowski P, Liu JW, Jin MX, Liu Z, Suciu-Foca N, Hardy MA.
    Transplant Proc; 2005 Feb 15; 37(1):43-5. PubMed ID: 15808541
    [Abstract] [Full Text] [Related]

  • 8. Improved survival from potentially lethal graft-vs.-host disease by donor pretreatment with a recipient-specific blood transfusion. I. Requirements for induction and specificity of the effect.
    Knulst AC, Bril-Bazuin C, Tibbe GJ, Benner R.
    Eur J Immunol; 1992 Oct 15; 22(10):2481-6. PubMed ID: 1396955
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induction of nonspecific x-irradiation-resistant suppressor cell activity in vivo and prolongation of vascularized allograft survival by SK&F 105685, a novel immunomodulatory azaspirane.
    Schmidbauer G, Hancock WW, Badger AM, Kupiec-Weglinski JW.
    Transplantation; 1993 Jun 15; 55(6):1236-43. PubMed ID: 8516808
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mechanism of skin allograft enhancement across an H-2 class I mutant difference. Evidence for involvement of veto cells.
    Kast WM, Van Twuyver E, Mooijaart RJ, Verveld M, Kamphuis AG, Melief CJ, De Waal LP.
    Eur J Immunol; 1988 Dec 15; 18(12):2105-8. PubMed ID: 2975604
    [Abstract] [Full Text] [Related]

  • 15. Are DST/allograft-induced suppressor cells donor specific?
    Wakely E, Cutkomp J, Corry RJ.
    Transplant Proc; 1989 Feb 15; 21(1 Pt 1):488-90. PubMed ID: 2523147
    [No Abstract] [Full Text] [Related]

  • 16. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage.
    Tchervenkov JI, Cofer BR, Davies C, Alexander JW.
    Transplantation; 1995 Mar 27; 59(6):821-4. PubMed ID: 7701575
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.